Quantcast

Latest Becker's muscular dystrophy Stories

2009-02-17 14:00:00

Legendary Broadcaster and Humanitarian Helps Launch Event Honoring Local Boy CHICAGO, Feb. 17 /PRNewswire-USNewswire/ -- John C. Hiatt, President and Founder of the Liam Hiatt Foundation along with his wife, Paula, announced the first annual "Liam Hiatt Art of Living Gala" on February 28, 2009, to be hosted by legendary broadcaster and humanitarian, Bill Kurtis. This Gala represents the first fundraising event for the newly created foundation, named after the Hiatt's eight year old grandson...

2009-02-09 17:44:19

A new class of experimental drugs for heart failure may also help treat a fatal muscular disorder, U.S. researchers discovered. Researchers at Columbia University Medical Center in New York said the medication might be effective even though heart failure and the muscle-wasting Duchenne disease couldn't appear more dissimilar. Duchenne affects boys, usually before age 6, destroying muscle cells and making them progressively weaker. Many victims die in their 20s. People with heart failure are...

2009-02-09 07:58:57

Drugs similar to 1 in trials for heart disease may slow muscle loss in most common form of muscular dystrophy Based on a striking similarity between heart disease and Duchenne muscular dystrophy, researchers at Columbia University Medical Center have discovered that a new class of experimental drugs for heart failure may also help treat the fatal muscular disorder. At first glance, heart failure and the muscle-wasting Duchenne disease couldn't appear more dissimilar. Duchenne affects boys...

2009-02-03 07:00:00

- Ataluren designated as generic name for PTC124 - SOUTH PLAINFIELD, N.J., Feb. 3 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced that it has successfully completed patient enrollment of its pivotal clinical trial of PTC124 in patients with nonsense mutation Duchenne and Becker muscular dystrophy (nmDMD/BMD). Accrual was completed two months ahead of schedule. The company also announced today that PTC124 has been issued the generic name, ataluren. (Logo:...

2009-01-23 13:47:00

Online Resource Links Patients With Researchers, Clinicians MIDDLETOWN, Ohio, Jan. 23 /PRNewswire-USNewswire/ -- Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced the one year anniversary of DuchenneConnect, a central online arena linking the resources and needs of the Duchenne and Becker muscular dystrophy...

2008-12-23 09:02:00

Brown University to Receive Grant Promoting Translational Research in Rare Muscular Disease MIDDLETOWN, Ohio, Dec. 23 /PRNewswire-USNewswire/ -- Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today the first grant recipient of the newly launched End Duchenne Grant Award Program, Brown University. Brown...

33c766a87ec10dc64358bf1455e0e40e1
2008-10-30 08:40:00

Feeling tired? Researchers say Viagra could help alleviate your fatigue. A team at the University of Iowa found the drug helped animals with the mislocalized enzyme called neuronal nitric oxide synthase (nNOS). They also revealed a difference between the prolonged fatigue after mild exercise in muscular dystrophy patients and the inherent muscle weakness caused by the disease. The studies found a faulty signaling pathway that leads to exercise-induced fatigue in mouse models of muscular...

2008-10-14 12:00:32

AVI BioPharma, Inc. (NASDAQ: AVII), a developer of RNA-based drugs, today announced that the Company -- along with The Foundation to Eradicate Duchenne, the CureDuchenne Foundation, and Prosensa -- will co-host an exon skipping conference for Duchenne muscular dystrophy (DMD) from October 14-17, 2008 at the Banbury Center of Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. Invited participants will be drawn from all over the world and from all areas of research, clinical development,...

2008-10-14 06:00:36

The Foundation to Eradicate Duchenne (FED), the CureDuchenne Foundation, AVI BioPharma and Prosensa will host an Exon Skipping Conference for Duchenne Muscular Dystrophy from October 14 -17, 2008 at the Banbury Center of Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. Participants are being drawn from a wide area of research, from chemistry to regulatory authorities, to critically review progress on oligonucleotides as therapeutic agents for Duchenne Muscular Dystrophy. Over the...

2008-10-09 12:00:17

By Adam Morris A CHARITY is in talks with the Scottish Government to create a specialist centre for muscular dystrophy in Edinburgh. Action Duchenne has held several meetings with senior figures in Holyrood about the possibility of creating the facility, which would serve the whole country. Recent reports have suggested sufferers of the degenerative, muscle-wasting illness north of the Border not only have a poorer quality of life, but live shorter than those in England and Europe,...


Word of the Day
baudekin
  • A rich embroidered or brocaded silk fabric woven originally with a warp of gold thread.
'Baudekin' seems to be an alternative form of 'baldachin,' from the Italian 'Baldacco,' Baghdad, the city where the material was made.
Related